1. Home
  2. AKTX vs ZEO Comparison

AKTX vs ZEO Comparison

Compare AKTX & ZEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AKTX
  • ZEO
  • Stock Information
  • Founded
  • AKTX N/A
  • ZEO 2005
  • Country
  • AKTX United States
  • ZEO United States
  • Employees
  • AKTX N/A
  • ZEO N/A
  • Industry
  • AKTX Biotechnology: Pharmaceutical Preparations
  • ZEO
  • Sector
  • AKTX Health Care
  • ZEO
  • Exchange
  • AKTX Nasdaq
  • ZEO NYSE
  • Market Cap
  • AKTX 41.8M
  • ZEO 55.5M
  • IPO Year
  • AKTX N/A
  • ZEO N/A
  • Fundamental
  • Price
  • AKTX $1.17
  • ZEO $2.79
  • Analyst Decision
  • AKTX
  • ZEO
  • Analyst Count
  • AKTX 0
  • ZEO 0
  • Target Price
  • AKTX N/A
  • ZEO N/A
  • AVG Volume (30 Days)
  • AKTX 27.5K
  • ZEO 99.9K
  • Earning Date
  • AKTX 08-18-2025
  • ZEO 06-16-2025
  • Dividend Yield
  • AKTX N/A
  • ZEO N/A
  • EPS Growth
  • AKTX N/A
  • ZEO N/A
  • EPS
  • AKTX N/A
  • ZEO N/A
  • Revenue
  • AKTX N/A
  • ZEO $61,885,622.00
  • Revenue This Year
  • AKTX N/A
  • ZEO N/A
  • Revenue Next Year
  • AKTX N/A
  • ZEO N/A
  • P/E Ratio
  • AKTX N/A
  • ZEO N/A
  • Revenue Growth
  • AKTX N/A
  • ZEO N/A
  • 52 Week Low
  • AKTX $0.85
  • ZEO $1.05
  • 52 Week High
  • AKTX $4.40
  • ZEO $4.75
  • Technical
  • Relative Strength Index (RSI)
  • AKTX 45.49
  • ZEO 50.81
  • Support Level
  • AKTX $1.10
  • ZEO $2.63
  • Resistance Level
  • AKTX $1.18
  • ZEO $3.25
  • Average True Range (ATR)
  • AKTX 0.07
  • ZEO 0.39
  • MACD
  • AKTX 0.00
  • ZEO -0.09
  • Stochastic Oscillator
  • AKTX 53.25
  • ZEO 36.43

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy-efficient equipment, and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

Share on Social Networks: